Univest
Univest
  • Markets

Viyash Scientific Share Price in Focus as Carlyle Group-Linked Promoters Sell 10.88% Stake for Rs 1,259 Crore

  • August 27, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
Viyash Scientific Share Price in Focus as Carlyle Group-Linked Promoters Sell 10.88% Stake for Rs 1,259 Crore

Viyash Scientific: Carlyle-linked promoters CA Hull and CA Harbor Investments sold 4.75 Cr shares (10.88% stake) for Rs 1,259.4 Cr. Carlyle held 61.31% as of June 2026.

Quick Answer

Viyash Scientific share price is in focus after promoters CA Hull Investments and CA Harbor Investments, both owned by global investment firm The Carlyle Group, sold 4.75 crore equity shares for Rs 1,259.4 crore. The stake sold was equivalent to 10.88% of the company’s paid-up equity, with six institutional investors picking up the shares.

Viyash Scientific share price is in focus after promoters CA Hull Investments and CA Harbor Investments, both owned by global investment firm The Carlyle Group, sold 4.75 crore equity shares in the company for Rs 1,259.4 crore at different prices. The stake sold was equivalent to 10.88% of Viyash Scientific’s paid-up equity.

The Carlyle Group held a 61.31% stake in Viyash Scientific as of June 2026, meaning the sale reduces but does not eliminate the private equity firm’s substantial ownership position in the company. Of the stake sold, 1.08 crore shares were picked up by six investors, including Kotak Mahindra AMC, Bandhan MF, Edelweiss MF, Panvira India Innovation Fund, S Gupta Homes, and Aagam Investments.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • About Viyash Scientific
  • Who Bought the Stake Sold by Carlyle?
  • Viyash Scientific Stake Sale Details
  • Conclusion
  • FAQs on Viyash Scientific Share Price
    • Why is Viyash Scientific share price in focus today?
    • Who are Viyash Scientific’s promoters?
    • How much stake does Carlyle still hold in Viyash Scientific?
    • Who bought the Viyash Scientific shares sold by Carlyle?
    • Is Carlyle exiting Viyash Scientific completely?

About Viyash Scientific

Viyash Scientific is a company that has attracted significant private equity backing from The Carlyle Group, one of the world’s largest alternative asset managers. Carlyle’s continued majority ownership, even after this partial exit, indicates the firm retains a substantial long-term interest in the company’s growth trajectory.

Who Bought the Stake Sold by Carlyle?

Track Viyash Scientific’s live price on the Univest Screener

A mix of domestic mutual funds and other institutional investors participated in the block deal, including Kotak Mahindra AMC, Bandhan MF, and Edelweiss MF. The presence of well-established domestic mutual fund houses among the buyers is generally viewed as a positive signal, as it suggests institutional confidence in the company’s fundamentals at the transacted price levels.

Viyash Scientific Stake Sale Details

Parameter Details
Sellers CA Hull Investments and CA Harbor Investments (Carlyle Group entities)
Shares Sold 4.75 crore equity shares
Stake Sold 10.88% of paid-up equity
Transaction Value Rs 1,259.4 crore
Carlyle’s Pre-Sale Stake 61.31% (as of June 2026)
Key Buyers Kotak Mahindra AMC, Bandhan MF, Edelweiss MF, Panvira India Innovation Fund, S Gupta Homes, Aagam Investments

Conclusion

Viyash Scientific share price will remain in focus as the market absorbs this significant stake sale by Carlyle Group-linked promoters. The participation of established domestic mutual funds among the buyers suggests institutional confidence, though Carlyle’s continued majority ownership means further stake sales cannot be ruled out over time. Consult a SEBI-registered financial advisor before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Download the Univest iOS App or Univest Android App to track Viyash Scientific’s live price after the stake sale.

FAQs on Viyash Scientific Share Price

Why is Viyash Scientific share price in focus today?

Ans. Viyash Scientific share price is in focus after Carlyle Group-linked promoters CA Hull Investments and CA Harbor Investments sold a combined 10.88% stake for Rs 1,259.4 crore through block deals.

Who are Viyash Scientific’s promoters?

Ans. Viyash Scientific’s promoters are CA Hull Investments and CA Harbor Investments, both entities owned by the global investment firm The Carlyle Group.

How much stake does Carlyle still hold in Viyash Scientific?

Ans. The Carlyle Group held a 61.31% stake in Viyash Scientific as of June 2026, before this reported stake sale of 10.88%. Even after the sale, Carlyle retains a substantial majority position in the company.

Who bought the Viyash Scientific shares sold by Carlyle?

Ans. Six institutional investors picked up 1.08 crore of the shares sold by Carlyle, including Kotak Mahindra AMC, Bandhan MF, Edelweiss MF, Panvira India Innovation Fund, S Gupta Homes, and Aagam Investments.

Is Carlyle exiting Viyash Scientific completely?

Ans. No, this transaction represents a partial stake sale of 10.88%. Carlyle Group’s associated entities retained a majority stake of over 50% in Viyash Scientific even after this sale, indicating a continued long-term interest in the company.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply